Skip to main content
Erschienen in: Journal of Anesthesia 1/2010

01.02.2010 | Review Article

Possible indications of beta-blockers in the perioperative period other than prevention of cardiac ischemia

verfasst von: Yuji Kadoi, Shigeru Saito

Erschienen in: Journal of Anesthesia | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Abstract

According to the guidelines of the American College of Cardiology/American Heart Association 2006 for perioperative cardiovascular evaluation for non-cardiac surgery, beta-blocker therapy should be considered for high-risk individuals undergoing vascular surgery or high- and intermediate-risk patients undergoing non-cardiac surgery. This guideline might induce physicians to increasingly use beta-blockers in the hope of preventing perioperative cardiac complications. However, beta-blockers have potential beneficial effects outside the prevention of cardiac events. In addition to reducing anesthetic and analgesic requirements during the perioperative period, beta-blockers have neuroprotective effects in patients with brain trauma and possible effectiveness in the management of intraoperative awareness-induced post-traumatic stress disorder. Moreover, intrathecal administration of beta-blockers may have antinociceptive effects. Physicians need to bear in mind the benefits of beta-blockers for purposes other than preventing cardiac events when applied in the perioperative period, and they should be familiar with the pharmacodynamics and risk–benefit ratio with their use. This review focuses on possible extracardiac indications of beta-blockers.
Literatur
1.
Zurück zum Zitat London MJ, Zaugg M, Schaub MC, Spahn DR. Perioperative beta-adrenergic receptor blockade. Anesthesiology. 2004;100:170–5.PubMedCrossRef London MJ, Zaugg M, Schaub MC, Spahn DR. Perioperative beta-adrenergic receptor blockade. Anesthesiology. 2004;100:170–5.PubMedCrossRef
2.
Zurück zum Zitat Fleisher LA, Beckman JA, Brown KA, Calkins H, Charikof EL, Fleischmann KE, et al. ACC/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative beta-blocker therapy. Circulation. 2006;113:2662–74.PubMedCrossRef Fleisher LA, Beckman JA, Brown KA, Calkins H, Charikof EL, Fleischmann KE, et al. ACC/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative beta-blocker therapy. Circulation. 2006;113:2662–74.PubMedCrossRef
3.
Zurück zum Zitat Prichard BNC. Beta-adrenergic receptor blockade in hypertension, past, present and future. Br J Clin Pharmacol. 1978;5:379–99.PubMed Prichard BNC. Beta-adrenergic receptor blockade in hypertension, past, present and future. Br J Clin Pharmacol. 1978;5:379–99.PubMed
4.
Zurück zum Zitat Zaugg M, Schaub MC, Pasch T, Spahn DR. Modulation of beta-adrenergic receptor subtype activities in perioperative medicine: mechanisms and sites of action. Br J Anaesth. 2002;88:101–23.PubMedCrossRef Zaugg M, Schaub MC, Pasch T, Spahn DR. Modulation of beta-adrenergic receptor subtype activities in perioperative medicine: mechanisms and sites of action. Br J Anaesth. 2002;88:101–23.PubMedCrossRef
5.
Zurück zum Zitat Zaugg M, Tagliente T, Lucchinetti E, Jacobs E, Krol M, Bodian C, et al. Beneficial effects from beta-adrenergic blockade in elderly patients undergoing noncardiac surgery. Anesthesiology. 1999;91:1674–86.PubMedCrossRef Zaugg M, Tagliente T, Lucchinetti E, Jacobs E, Krol M, Bodian C, et al. Beneficial effects from beta-adrenergic blockade in elderly patients undergoing noncardiac surgery. Anesthesiology. 1999;91:1674–86.PubMedCrossRef
6.
Zurück zum Zitat Johansen JW, Schneider G, Windsor AM, Sebel PS. Esmolol potentiates reduction of minimum alveolar isoflurane concentration by alfentanil. Anesth Analg. 1998;87:671–6.PubMedCrossRef Johansen JW, Schneider G, Windsor AM, Sebel PS. Esmolol potentiates reduction of minimum alveolar isoflurane concentration by alfentanil. Anesth Analg. 1998;87:671–6.PubMedCrossRef
7.
Zurück zum Zitat Johansen JW, Flaishon R, Sebel PS. Esmolol reduces anesthetic requirement for skin incision during propofol/nitrous oxide/morphine anesthesia. Anesthesiology. 1997;86:361–71.CrossRef Johansen JW, Flaishon R, Sebel PS. Esmolol reduces anesthetic requirement for skin incision during propofol/nitrous oxide/morphine anesthesia. Anesthesiology. 1997;86:361–71.CrossRef
8.
Zurück zum Zitat Stanley TH, Lange SD, Boscoe MJ, Bruun ND. The influence of chronic preoperative propranolol therapy on cardiovascular dynamics and narcotic requirements during operation in patients with coronary artery disease. Can J Anaesth. 1982;29:319–24.CrossRef Stanley TH, Lange SD, Boscoe MJ, Bruun ND. The influence of chronic preoperative propranolol therapy on cardiovascular dynamics and narcotic requirements during operation in patients with coronary artery disease. Can J Anaesth. 1982;29:319–24.CrossRef
9.
Zurück zum Zitat Smith I, Hemelrijck JV, White PF. Efficacy of esmolol versus alfentanil as a supplement to propofol–nitrous oxide anesthesia. Anesth Analg. 1991;73:540–6.PubMed Smith I, Hemelrijck JV, White PF. Efficacy of esmolol versus alfentanil as a supplement to propofol–nitrous oxide anesthesia. Anesth Analg. 1991;73:540–6.PubMed
10.
Zurück zum Zitat Johansen JW. Esmolol promotes electroencephalographic burst suppression during propofol/alfentanil anesthesia. Anesth Analg. 2001;93:1526–31.PubMedCrossRef Johansen JW. Esmolol promotes electroencephalographic burst suppression during propofol/alfentanil anesthesia. Anesth Analg. 2001;93:1526–31.PubMedCrossRef
11.
Zurück zum Zitat Coloma M, Chu JW, White PF, Armbruster SC. The use of esmolol as an alternative to remifentanil during desflurane anesthesia for fast-track outpatient gynecologic laparoscopic surgery. Anesth Analg. 2001;92:352–7.PubMedCrossRef Coloma M, Chu JW, White PF, Armbruster SC. The use of esmolol as an alternative to remifentanil during desflurane anesthesia for fast-track outpatient gynecologic laparoscopic surgery. Anesth Analg. 2001;92:352–7.PubMedCrossRef
12.
Zurück zum Zitat Menigaux C, Guignard B, Adam F, Sessler DI, Joly V, Chauvin M. Esmolol prevents movement and attenuates the BIS response to orotracheal intubation. Br J Anaesth. 2002;89:857–62.PubMedCrossRef Menigaux C, Guignard B, Adam F, Sessler DI, Joly V, Chauvin M. Esmolol prevents movement and attenuates the BIS response to orotracheal intubation. Br J Anaesth. 2002;89:857–62.PubMedCrossRef
13.
Zurück zum Zitat Zaugg M, Tagliente T, Silverstein JH, Lucchinetti E. Atenolol may not modify anesthetic depth indicators in elderly patients––a second look at the data. Can J Anaesth. 2003;50:638–42.PubMedCrossRef Zaugg M, Tagliente T, Silverstein JH, Lucchinetti E. Atenolol may not modify anesthetic depth indicators in elderly patients––a second look at the data. Can J Anaesth. 2003;50:638–42.PubMedCrossRef
14.
Zurück zum Zitat Berkenstadt H, Loebstein R, Faibishenko I, Halkin H, Keidan I, Perel A. Effect of a single dose of esmolol on the bispectral index scale (BIS) during propofol/fentanyl anesthesia. Br J Anaesth. 2002;89:509–11.PubMedCrossRef Berkenstadt H, Loebstein R, Faibishenko I, Halkin H, Keidan I, Perel A. Effect of a single dose of esmolol on the bispectral index scale (BIS) during propofol/fentanyl anesthesia. Br J Anaesth. 2002;89:509–11.PubMedCrossRef
15.
Zurück zum Zitat Wilson ES, McKinlay S, Crawford JM, Robb HM. The influence of esmolol on the dose of propofol required for induction of anesthesia. Anaesthesia. 2004;59:122–6.PubMedCrossRef Wilson ES, McKinlay S, Crawford JM, Robb HM. The influence of esmolol on the dose of propofol required for induction of anesthesia. Anaesthesia. 2004;59:122–6.PubMedCrossRef
16.
Zurück zum Zitat Ghosh I, Bithal PK, Dash HH, Chaturvedi A, Prabhakar H. Both clonidine and metoprolol modify anesthetic depth indicators and reduce intraoperative propofol requirement. J Anesth. 2008;22:131–4.PubMedCrossRef Ghosh I, Bithal PK, Dash HH, Chaturvedi A, Prabhakar H. Both clonidine and metoprolol modify anesthetic depth indicators and reduce intraoperative propofol requirement. J Anesth. 2008;22:131–4.PubMedCrossRef
17.
Zurück zum Zitat Collard V, Mistraletti G, Taqi A, Asenjo JF, Feldman LS, Fried GM, et al. Intraoperative esmolol infusion in the absence of opioids spares postoperative fentanyl in patients undergoing ambulatory laparoscopic cholecystectomy. Anesth Analg. 2007;105:1255–62.PubMedCrossRef Collard V, Mistraletti G, Taqi A, Asenjo JF, Feldman LS, Fried GM, et al. Intraoperative esmolol infusion in the absence of opioids spares postoperative fentanyl in patients undergoing ambulatory laparoscopic cholecystectomy. Anesth Analg. 2007;105:1255–62.PubMedCrossRef
18.
Zurück zum Zitat Tanifuji Y, Eger EI II. Effect of isoproterenol and propranolol on halothane MAC in dogs. Anesth Analg. 1976;55:383–7.PubMedCrossRef Tanifuji Y, Eger EI II. Effect of isoproterenol and propranolol on halothane MAC in dogs. Anesth Analg. 1976;55:383–7.PubMedCrossRef
19.
Zurück zum Zitat Orme R, Leslie K, Umranikar A, Ugoni A. Esmolol and anesthetic requirement for loss of responsiveness during propofol anesthesia. Anesth Analg. 2002;93:112–6.CrossRef Orme R, Leslie K, Umranikar A, Ugoni A. Esmolol and anesthetic requirement for loss of responsiveness during propofol anesthesia. Anesth Analg. 2002;93:112–6.CrossRef
20.
Zurück zum Zitat Larson MD, Sessler DI, Washington DE, Merrifield BR, Hynson JA, McGuire J. Pupillary response to noxious stimulation during isoflurane and propofol anesthesia. Anesth Analg. 1993;76:1072–8.PubMedCrossRef Larson MD, Sessler DI, Washington DE, Merrifield BR, Hynson JA, McGuire J. Pupillary response to noxious stimulation during isoflurane and propofol anesthesia. Anesth Analg. 1993;76:1072–8.PubMedCrossRef
21.
Zurück zum Zitat Iguchi S, Iwamura H, Nishizaki M, Hayashi A, Senokuchi K, Kobayashi K, et al. Development of a highly cardioselective ultra-short-acting beta-blocker, ONO-1101. Chem Pharm Bull. 1992;40:1462–9.PubMed Iguchi S, Iwamura H, Nishizaki M, Hayashi A, Senokuchi K, Kobayashi K, et al. Development of a highly cardioselective ultra-short-acting beta-blocker, ONO-1101. Chem Pharm Bull. 1992;40:1462–9.PubMed
22.
Zurück zum Zitat Atarashi H, Kuruma A, Yashima M, Saitoh H, Ino T, Endoh Y, et al. Pharmacokinetics of landiolol hydrochloride, a new ultra-short-acting beta-blocker, in patients with cardiac arrhythmias. Clin Pharmacol Ther. 2000;68:143–50.PubMedCrossRef Atarashi H, Kuruma A, Yashima M, Saitoh H, Ino T, Endoh Y, et al. Pharmacokinetics of landiolol hydrochloride, a new ultra-short-acting beta-blocker, in patients with cardiac arrhythmias. Clin Pharmacol Ther. 2000;68:143–50.PubMedCrossRef
23.
Zurück zum Zitat Sasao J, Traver SD, Kindscher JD, Taneyama C, Benson KT, Goto H. In rabbits, landiolol, a new ultra-short-acting beta blocker, exerts a more potent negative chronotropic effect and less effect on blood pressure than esmolol. Can J Anaesth. 2001;48:985–9.PubMedCrossRef Sasao J, Traver SD, Kindscher JD, Taneyama C, Benson KT, Goto H. In rabbits, landiolol, a new ultra-short-acting beta blocker, exerts a more potent negative chronotropic effect and less effect on blood pressure than esmolol. Can J Anaesth. 2001;48:985–9.PubMedCrossRef
24.
Zurück zum Zitat Kurita T, Takata K, Morita K, Sato S. Lipophilic beta-adrenoceptor antagonist propranolol increases the hypnotic and anti-nociceptive effects of isoflurane in a swine model. Br J Anaesth. 2008;100:841–5.PubMedCrossRef Kurita T, Takata K, Morita K, Sato S. Lipophilic beta-adrenoceptor antagonist propranolol increases the hypnotic and anti-nociceptive effects of isoflurane in a swine model. Br J Anaesth. 2008;100:841–5.PubMedCrossRef
25.
Zurück zum Zitat Tanabe T, Fukusaki M, Fujinaga A, Ando Y, Yamashita K, Terao Y, et al. Landiolol, a new ultra-short-acting beta 1-blocker, reduces anesthetic requirement during sevoflurane/N2O/fentanyl anesthesia in surgical patients. Eur J Anaesthesiol. 2009;26:39–42.PubMedCrossRef Tanabe T, Fukusaki M, Fujinaga A, Ando Y, Yamashita K, Terao Y, et al. Landiolol, a new ultra-short-acting beta 1-blocker, reduces anesthetic requirement during sevoflurane/N2O/fentanyl anesthesia in surgical patients. Eur J Anaesthesiol. 2009;26:39–42.PubMedCrossRef
26.
Zurück zum Zitat Kurita T, Takata K, Uraoka M, Morita K, Sato S. Landiolol, an ultra-short-acting beta 1-adrenoceptor antagonist, does not alter the minimum alveolar anesthetic concentration of isoflurane in a swine model. Anesth Analg. 2007;105:656–60.PubMedCrossRef Kurita T, Takata K, Uraoka M, Morita K, Sato S. Landiolol, an ultra-short-acting beta 1-adrenoceptor antagonist, does not alter the minimum alveolar anesthetic concentration of isoflurane in a swine model. Anesth Analg. 2007;105:656–60.PubMedCrossRef
27.
Zurück zum Zitat Kurita T, Morita K, Fukuda K, Takata K, Uraoka M, Sanjo Y, et al. Landiolol, an ultra-short-acting beta 1-adrenoceptor antagonist, dose not alter the electroencephalographic effect of isoflurane in swine model. Br J Anaesth. 2006;96:602–7.PubMedCrossRef Kurita T, Morita K, Fukuda K, Takata K, Uraoka M, Sanjo Y, et al. Landiolol, an ultra-short-acting beta 1-adrenoceptor antagonist, dose not alter the electroencephalographic effect of isoflurane in swine model. Br J Anaesth. 2006;96:602–7.PubMedCrossRef
29.
Zurück zum Zitat Ginsburg RS. Is intravenous esmolol an acceptable substitute for an inadequate anesthetic? Anesth Analg. 1982;74:76–777. Ginsburg RS. Is intravenous esmolol an acceptable substitute for an inadequate anesthetic? Anesth Analg. 1982;74:76–777.
30.
Zurück zum Zitat Rusell IF, Wang M. Absence of memory for intra-operative information during surgery with total intravenous anesthesia. Br J Anaesth. 2001;86:196–202.CrossRef Rusell IF, Wang M. Absence of memory for intra-operative information during surgery with total intravenous anesthesia. Br J Anaesth. 2001;86:196–202.CrossRef
31.
Zurück zum Zitat Upton RN, Ludbrook GL, Grant C, Martinez AM. Cardiac output is a determinant of the initial concentrations of propofol after short infusion administration. Anesth Analg. 1999;89:545–52.PubMedCrossRef Upton RN, Ludbrook GL, Grant C, Martinez AM. Cardiac output is a determinant of the initial concentrations of propofol after short infusion administration. Anesth Analg. 1999;89:545–52.PubMedCrossRef
32.
Zurück zum Zitat Antognini JF, Schwartz K. Exaggerated anesthetic requirements in the preferentially anesthetized brain. Anesthesiology. 1993;79:1244–9.PubMedCrossRef Antognini JF, Schwartz K. Exaggerated anesthetic requirements in the preferentially anesthetized brain. Anesthesiology. 1993;79:1244–9.PubMedCrossRef
33.
Zurück zum Zitat Borges M, Antognini JF. Does the brain influence somatic responses to noxious stimuli during isoflurane anesthesia? Anesthesiology. 1994;81:1511–5.PubMedCrossRef Borges M, Antognini JF. Does the brain influence somatic responses to noxious stimuli during isoflurane anesthesia? Anesthesiology. 1994;81:1511–5.PubMedCrossRef
34.
Zurück zum Zitat Rampil IJ, Mason P, Singh H. Anesthetic potency (MAC) is independent of forebrain structures in rats. Anesthesiology. 1993;78:707–12.PubMedCrossRef Rampil IJ, Mason P, Singh H. Anesthetic potency (MAC) is independent of forebrain structures in rats. Anesthesiology. 1993;78:707–12.PubMedCrossRef
35.
Zurück zum Zitat Davidson EM, Doursout MF, Szmuk P, Chelly JE. Antinociceptive and cardiovascular properties of esmolol following formalin injection in rats. Can J Anaesth. 2001;48:59–64.PubMedCrossRef Davidson EM, Doursout MF, Szmuk P, Chelly JE. Antinociceptive and cardiovascular properties of esmolol following formalin injection in rats. Can J Anaesth. 2001;48:59–64.PubMedCrossRef
36.
Zurück zum Zitat Taira Y, Kakinohana M, Kakinohana O, Okuda Y. ONO 1101, a novel ultra-short acting beta-1 blocker, can reduce pain behaviour in the rat formalin test. Anesthesiology. 1998;89:A1128.CrossRef Taira Y, Kakinohana M, Kakinohana O, Okuda Y. ONO 1101, a novel ultra-short acting beta-1 blocker, can reduce pain behaviour in the rat formalin test. Anesthesiology. 1998;89:A1128.CrossRef
37.
Zurück zum Zitat Kinjo S, Kakinohana M, Sugawara K. Esmolol and landiolol, ultra short acting beta-1 blockers can reduce pain behavior in the rat formalin test. Anesth Analg. 2005;100:S-265. Kinjo S, Kakinohana M, Sugawara K. Esmolol and landiolol, ultra short acting beta-1 blockers can reduce pain behavior in the rat formalin test. Anesth Analg. 2005;100:S-265.
38.
Zurück zum Zitat Zhao H, Sugawara T, Miura S, Iijima T, Kashimoto S. Intrathecal landiolol inhibits nociception and spinal c-Fos expression in the mouse formalin test. Can J Anaesth. 2007;54:201–7.PubMedCrossRef Zhao H, Sugawara T, Miura S, Iijima T, Kashimoto S. Intrathecal landiolol inhibits nociception and spinal c-Fos expression in the mouse formalin test. Can J Anaesth. 2007;54:201–7.PubMedCrossRef
39.
Zurück zum Zitat Chia YY, Chan MH, Ko NH, Liu K. Role of beta-blockade in anesthesia and postoperative pain management after hysterectomy. Br J Anaesth. 2004;93:799–805.PubMedCrossRef Chia YY, Chan MH, Ko NH, Liu K. Role of beta-blockade in anesthesia and postoperative pain management after hysterectomy. Br J Anaesth. 2004;93:799–805.PubMedCrossRef
40.
Zurück zum Zitat Tanahashi S, Iida H, Oda A, Osawa Y, Dohi S. Effect of beta-adrenoceptor antagonists on tetrodotoxin-resistant Na channels in rat dorsal root ganglion neurons. Anesthesiology. 2003;99:A–962. Tanahashi S, Iida H, Oda A, Osawa Y, Dohi S. Effect of beta-adrenoceptor antagonists on tetrodotoxin-resistant Na channels in rat dorsal root ganglion neurons. Anesthesiology. 2003;99:A–962.
41.
Zurück zum Zitat Berridge CW, Foote SL. Enhancement of Behavioral and electroencephalographic indices of waking following stimulation of noradrenergic beta-receptors within the medial septal region of the basal forebrain. J Neurosci. 1996;16:6999–7009.PubMed Berridge CW, Foote SL. Enhancement of Behavioral and electroencephalographic indices of waking following stimulation of noradrenergic beta-receptors within the medial septal region of the basal forebrain. J Neurosci. 1996;16:6999–7009.PubMed
42.
Zurück zum Zitat Berridge CW, White K. Contrasting effect of noradrenergic beta-receptor blockade within the median septal area on forebrain electroencephalographic and behavioral activity state in anesthetized and unanesthetized rat. Neuroscience. 2000;97:543–52.PubMedCrossRef Berridge CW, White K. Contrasting effect of noradrenergic beta-receptor blockade within the median septal area on forebrain electroencephalographic and behavioral activity state in anesthetized and unanesthetized rat. Neuroscience. 2000;97:543–52.PubMedCrossRef
43.
Zurück zum Zitat Berridge CW, Morris MF. Amphetamine-induced activation of forebrain EEG is prevented by noradrenergic beta-receptor blockade in the halothane-anesthetized rat. Psychopharmacology (Berl). 2000;148:307–13.CrossRef Berridge CW, Morris MF. Amphetamine-induced activation of forebrain EEG is prevented by noradrenergic beta-receptor blockade in the halothane-anesthetized rat. Psychopharmacology (Berl). 2000;148:307–13.CrossRef
44.
Zurück zum Zitat Radisavievic Z, Cepeda C, Peacock W, Buchwald NA, Levine MS. Norepinephrine modulates excitatory amino acid-induced responses in developing human and adult rat cerebral cortex. Int J Dev Neurosci. 1994;12:353–61.CrossRef Radisavievic Z, Cepeda C, Peacock W, Buchwald NA, Levine MS. Norepinephrine modulates excitatory amino acid-induced responses in developing human and adult rat cerebral cortex. Int J Dev Neurosci. 1994;12:353–61.CrossRef
45.
Zurück zum Zitat Howie MB, Bloack HA, Zvara D, McSweeney TD, Martin DJ, Coffman JA. Esmolol reduces automatic hypersensitivity and length of seizures induced by electroconvulsive therapy. Anesth Analg. 1990;71:384–8.PubMedCrossRef Howie MB, Bloack HA, Zvara D, McSweeney TD, Martin DJ, Coffman JA. Esmolol reduces automatic hypersensitivity and length of seizures induced by electroconvulsive therapy. Anesth Analg. 1990;71:384–8.PubMedCrossRef
46.
Zurück zum Zitat Van den Broek WW, Leentjens AFG, Mulder PGF, Kusuma A, Bruijn JA. Low-dose esmolol bolus reduces seizure duration during electroconvulsive therapy: a double-blind, placebo-controlled study. Br J Anaesth. 1999;83:271–4.PubMed Van den Broek WW, Leentjens AFG, Mulder PGF, Kusuma A, Bruijn JA. Low-dose esmolol bolus reduces seizure duration during electroconvulsive therapy: a double-blind, placebo-controlled study. Br J Anaesth. 1999;83:271–4.PubMed
47.
Zurück zum Zitat Kovac AL, Goto H, Arakawa K. Esmolol bolus and infusion attenuates increases in blood pressure and heart rate during electroconvulsive therapy. Can J Anaesth. 1990;37:58–62.PubMedCrossRef Kovac AL, Goto H, Arakawa K. Esmolol bolus and infusion attenuates increases in blood pressure and heart rate during electroconvulsive therapy. Can J Anaesth. 1990;37:58–62.PubMedCrossRef
48.
Zurück zum Zitat Drummond PD. Noradrenaline increases hyperalgesia to heat in skin sensitized by capsaicin. Pain. 1995;60:311–5.PubMedCrossRef Drummond PD. Noradrenaline increases hyperalgesia to heat in skin sensitized by capsaicin. Pain. 1995;60:311–5.PubMedCrossRef
49.
Zurück zum Zitat Khasar SG. Epinephrine produces a beta-adrenergic receptor-mediated mechanical hyperalgesia and in vitro sensitization of rat nociceptors. J Neurophysiol. 1999;81:1104–12.PubMed Khasar SG. Epinephrine produces a beta-adrenergic receptor-mediated mechanical hyperalgesia and in vitro sensitization of rat nociceptors. J Neurophysiol. 1999;81:1104–12.PubMed
50.
Zurück zum Zitat Garabededian BS, Poole S, Haddad JJ, Massaad CA, Jabbur SJ, Saade NE. The role of the sympathetic efferents in endotoxin-induced localized inflammatory hyperalgesia and cytokine upregulation. Neuropharmacology. 2002;42:864–72.CrossRef Garabededian BS, Poole S, Haddad JJ, Massaad CA, Jabbur SJ, Saade NE. The role of the sympathetic efferents in endotoxin-induced localized inflammatory hyperalgesia and cytokine upregulation. Neuropharmacology. 2002;42:864–72.CrossRef
51.
Zurück zum Zitat Cunha FQ, Lorenzetti BB, Poole S, Ferreira SH. Interleukin-8 as a mediator of sympathetic pain. Br J Pharmacol. 1991;104:765–7.PubMed Cunha FQ, Lorenzetti BB, Poole S, Ferreira SH. Interleukin-8 as a mediator of sympathetic pain. Br J Pharmacol. 1991;104:765–7.PubMed
52.
Zurück zum Zitat Ernberg M, Lundeberg T, Kopp S. Effect of propranolol and granisetron on experimentally induced pain and allodynia/hyperalgesia b intramuscular injection of serotonin into the human masseter muscle. Pain. 2000;84:339–46.PubMedCrossRef Ernberg M, Lundeberg T, Kopp S. Effect of propranolol and granisetron on experimentally induced pain and allodynia/hyperalgesia b intramuscular injection of serotonin into the human masseter muscle. Pain. 2000;84:339–46.PubMedCrossRef
53.
Zurück zum Zitat Ko DT, Hebert PR, Coffey CS, Sedrakyan A, Curtis JP, Krumholz HM. Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA. 2002;288:351–7.PubMedCrossRef Ko DT, Hebert PR, Coffey CS, Sedrakyan A, Curtis JP, Krumholz HM. Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA. 2002;288:351–7.PubMedCrossRef
54.
Zurück zum Zitat Brismar K, Hylander B, Eliasson K, Rossner S, Wetterberg L. Melatonin secretion related to side-effects of beta-blockers from the central nervous system. Acta Med Scand. 1988;223:525–30.PubMed Brismar K, Hylander B, Eliasson K, Rossner S, Wetterberg L. Melatonin secretion related to side-effects of beta-blockers from the central nervous system. Acta Med Scand. 1988;223:525–30.PubMed
55.
Zurück zum Zitat Kostis JB, Rosen RC. Central nervous system effects of beta-adrenergic blocking drugs: the role of ancillary properties. Circulation. 1987;75:204–12.PubMed Kostis JB, Rosen RC. Central nervous system effects of beta-adrenergic blocking drugs: the role of ancillary properties. Circulation. 1987;75:204–12.PubMed
56.
Zurück zum Zitat Betts TA, Alford C. Beta-blockers and sleep: a controlled trial. Eur J Clin Pharmacol. 1985;28:65–8.PubMedCrossRef Betts TA, Alford C. Beta-blockers and sleep: a controlled trial. Eur J Clin Pharmacol. 1985;28:65–8.PubMedCrossRef
57.
Zurück zum Zitat Van Stegeren AH, Everaerd W, Cahill L, McGaugh JL, Gooren LJG. Memory for emotional events: differential effects of centrally versus peripherally acting beta-blocking agents. Psychopharmacology. 1998;138:305–10.PubMedCrossRef Van Stegeren AH, Everaerd W, Cahill L, McGaugh JL, Gooren LJG. Memory for emotional events: differential effects of centrally versus peripherally acting beta-blocking agents. Psychopharmacology. 1998;138:305–10.PubMedCrossRef
58.
Zurück zum Zitat Przybyslawski J, Roullet P, Sara SJ. Attention of emotional and nonemotional memories after their reactivation: role of beta-adrenergic receptors. J Neurosci. 1999;19:6999–7009. Przybyslawski J, Roullet P, Sara SJ. Attention of emotional and nonemotional memories after their reactivation: role of beta-adrenergic receptors. J Neurosci. 1999;19:6999–7009.
59.
Zurück zum Zitat Gleiter CH, Deckert J. Adverse CNS-effects of beta-adrenoceptor blockers. Pharmacopsychiatry. 1996;29:201–11.PubMedCrossRef Gleiter CH, Deckert J. Adverse CNS-effects of beta-adrenoceptor blockers. Pharmacopsychiatry. 1996;29:201–11.PubMedCrossRef
60.
Zurück zum Zitat Nielson KA, Jensen RA. Beta-adrenergic receptor antagonist antihypertensive medications impair arousal-induced modulation of working memory in elderly humans. Behav Neural Biol. 1994;62:190–200.PubMedCrossRef Nielson KA, Jensen RA. Beta-adrenergic receptor antagonist antihypertensive medications impair arousal-induced modulation of working memory in elderly humans. Behav Neural Biol. 1994;62:190–200.PubMedCrossRef
61.
Zurück zum Zitat Yamada Y, Shibuya F, Hamada J, Sawada Y, Iga T. Prediction of sleep disorders induced by beta-adrenergic receptor blocking agents based on receptor occupancy. J Pharmacokinet Biopharm. 1995;23:131–45.PubMedCrossRef Yamada Y, Shibuya F, Hamada J, Sawada Y, Iga T. Prediction of sleep disorders induced by beta-adrenergic receptor blocking agents based on receptor occupancy. J Pharmacokinet Biopharm. 1995;23:131–45.PubMedCrossRef
62.
Zurück zum Zitat Brismar K, Moqensen L, Wetterberq L. Depressed melatonin secretion in patients with nightmares due to beta-adrenoceptor blocking drugs. Acta Med Scand. 1987;221:155–8.PubMed Brismar K, Moqensen L, Wetterberq L. Depressed melatonin secretion in patients with nightmares due to beta-adrenoceptor blocking drugs. Acta Med Scand. 1987;221:155–8.PubMed
63.
64.
Zurück zum Zitat Cahill L, Prins B, Weber M, McGaugh JL. Beta-adrenergic activation and memory for emotional events. Nature. 1994;371:702–4.PubMedCrossRef Cahill L, Prins B, Weber M, McGaugh JL. Beta-adrenergic activation and memory for emotional events. Nature. 1994;371:702–4.PubMedCrossRef
65.
Zurück zum Zitat McAinsh J, Cruickshank JM. Beta-blockers and central nervous system side effects. Pharmacol Ther. 1990;46:163–97.PubMedCrossRef McAinsh J, Cruickshank JM. Beta-blockers and central nervous system side effects. Pharmacol Ther. 1990;46:163–97.PubMedCrossRef
66.
Zurück zum Zitat Kayed K, Godtlibsen OB. Central effects of the beta-adrenergic blocking agent acebutolol. A quantitative EEG study using normalized slope descriptors. Eur J Clin Pharmacol. 1997;12:327–31.CrossRef Kayed K, Godtlibsen OB. Central effects of the beta-adrenergic blocking agent acebutolol. A quantitative EEG study using normalized slope descriptors. Eur J Clin Pharmacol. 1997;12:327–31.CrossRef
67.
Zurück zum Zitat Kayed K, Godtlibsen OB. Effects of the beta-adrenoceptor antagonists acebutolol and metoprolol on sleep pattern in normal subjects. Eur J Clin Pharmacol. 1977;16:323–6.CrossRef Kayed K, Godtlibsen OB. Effects of the beta-adrenoceptor antagonists acebutolol and metoprolol on sleep pattern in normal subjects. Eur J Clin Pharmacol. 1977;16:323–6.CrossRef
68.
Zurück zum Zitat Pitman RK, Sanders KM, Zusman RM, Healy AR, Cheema F, Lasko NB, et al. Pilot study of secondary prevention of posttraumatic stress disorder with propranolol. Biol Psychiatry. 2002;51:189–92.PubMedCrossRef Pitman RK, Sanders KM, Zusman RM, Healy AR, Cheema F, Lasko NB, et al. Pilot study of secondary prevention of posttraumatic stress disorder with propranolol. Biol Psychiatry. 2002;51:189–92.PubMedCrossRef
69.
70.
Zurück zum Zitat Lysko PG, Lysko KA, Yue TL, Webb CL, Gu JL, Feuerstein G. Neuroprotective effects of carvedilol, a new antihypertensive agent, in cultured rat cerebellar neurons and in gerbil global brain ischemia. Stroke. 1992;11:1630–5. Lysko PG, Lysko KA, Yue TL, Webb CL, Gu JL, Feuerstein G. Neuroprotective effects of carvedilol, a new antihypertensive agent, in cultured rat cerebellar neurons and in gerbil global brain ischemia. Stroke. 1992;11:1630–5.
71.
Zurück zum Zitat Savitz SI, Erhardt JA, Anthony JV, Gupta G, Li X, Barone FC, et al. The novel beta-blocker, carvedilol, provides neuroprotection in transient focal stroke. J Cereb Blood Flow Metab. 2000;8:1197–204.CrossRef Savitz SI, Erhardt JA, Anthony JV, Gupta G, Li X, Barone FC, et al. The novel beta-blocker, carvedilol, provides neuroprotection in transient focal stroke. J Cereb Blood Flow Metab. 2000;8:1197–204.CrossRef
72.
Zurück zum Zitat Amory DW, Grigore A, Amory JK, Gerhardt MA, White WD, Smith PK, et al. Neuroprotection is associated with beta-adrenergic receptor antagonists during cardiac surgery: evidence from 2,575 patients. J Cardiothorac Vasc Anesth. 2002;16:270–7.PubMedCrossRef Amory DW, Grigore A, Amory JK, Gerhardt MA, White WD, Smith PK, et al. Neuroprotection is associated with beta-adrenergic receptor antagonists during cardiac surgery: evidence from 2,575 patients. J Cardiothorac Vasc Anesth. 2002;16:270–7.PubMedCrossRef
73.
Zurück zum Zitat Inaba K, Teixeira PG, David JS, Chan LS, Salim A, Brown C, et al. Beta-blockers in isolated blunt head injury. J Am Coll Surg. 2008;206:432–8.PubMedCrossRef Inaba K, Teixeira PG, David JS, Chan LS, Salim A, Brown C, et al. Beta-blockers in isolated blunt head injury. J Am Coll Surg. 2008;206:432–8.PubMedCrossRef
74.
Zurück zum Zitat Riordan WP Jr, Cotton BA, Norris PR, Waitman LR, Jenkins JM, Morris JA Jr. Beta-blocker exposure in patients with severe traumatic brain injury (TBI) and cardiac uncoupling. J Trauma. 2007;63:503–10.PubMedCrossRef Riordan WP Jr, Cotton BA, Norris PR, Waitman LR, Jenkins JM, Morris JA Jr. Beta-blocker exposure in patients with severe traumatic brain injury (TBI) and cardiac uncoupling. J Trauma. 2007;63:503–10.PubMedCrossRef
75.
Zurück zum Zitat Arbabi S, Campion EM, Hemmila MR, Barker M, Dimo M, Ahrns KS, et al. Beta-blocker use is associated with improved outcomes in adult trauma patients. J Trauma. 2007;62:56–61.PubMedCrossRef Arbabi S, Campion EM, Hemmila MR, Barker M, Dimo M, Ahrns KS, et al. Beta-blocker use is associated with improved outcomes in adult trauma patients. J Trauma. 2007;62:56–61.PubMedCrossRef
76.
Zurück zum Zitat Cotton BA, Snodgrass KB, Fleming SB, Carpenter RO, Kemp CD, Arbogast PG, et al. Beta-blocker exposure is associated with improved survival after severe traumatic brain injury. J Trauma. 2007;62:26–33.PubMedCrossRef Cotton BA, Snodgrass KB, Fleming SB, Carpenter RO, Kemp CD, Arbogast PG, et al. Beta-blocker exposure is associated with improved survival after severe traumatic brain injury. J Trauma. 2007;62:26–33.PubMedCrossRef
77.
Zurück zum Zitat Martin M, Mullenix P, Rhee P, Belzberg H, Demetriades D, Salim A. Troponin increases in the critically injured patient: mechanical trauma or physiologic stress? J Trauma. 2005;59:1086–91.PubMedCrossRef Martin M, Mullenix P, Rhee P, Belzberg H, Demetriades D, Salim A. Troponin increases in the critically injured patient: mechanical trauma or physiologic stress? J Trauma. 2005;59:1086–91.PubMedCrossRef
78.
Zurück zum Zitat Little JR, Latchaw JP Jr, Slugg RM, Stowe NT. Treatment of acute focal cerebral ischemia with propranolol. Stroke. 1982;13:302–7.PubMed Little JR, Latchaw JP Jr, Slugg RM, Stowe NT. Treatment of acute focal cerebral ischemia with propranolol. Stroke. 1982;13:302–7.PubMed
79.
Zurück zum Zitat Standefer M, Little JR. Improved neurological outcome in experimental focal cerebral ischemia treated with propranolol. Neurosurgery. 1986;18:136–40.PubMedCrossRef Standefer M, Little JR. Improved neurological outcome in experimental focal cerebral ischemia treated with propranolol. Neurosurgery. 1986;18:136–40.PubMedCrossRef
80.
Zurück zum Zitat Junker V, Becker A, Huhne R, Zembatov M, Ravati A, Culmsee C, et al. Stimulation of beta-adrenoceptors activates astrocytes. Eur J Pharmacol. 2002;446:25–36.PubMedCrossRef Junker V, Becker A, Huhne R, Zembatov M, Ravati A, Culmsee C, et al. Stimulation of beta-adrenoceptors activates astrocytes. Eur J Pharmacol. 2002;446:25–36.PubMedCrossRef
81.
Zurück zum Zitat Goyagi T, Kimura T, Nishikawa T, Tobe Y, Masaki Y. Beta-adrenoceptor antagonist attenuates brain injury after transient focal ischemia in rats. Anesth Analg. 2006;103:658–63.PubMedCrossRef Goyagi T, Kimura T, Nishikawa T, Tobe Y, Masaki Y. Beta-adrenoceptor antagonist attenuates brain injury after transient focal ischemia in rats. Anesth Analg. 2006;103:658–63.PubMedCrossRef
82.
Zurück zum Zitat Goyagi T. Neuroprotection (in Japanese). J Jpn Clin Anesth. 2007;27:588–98.CrossRef Goyagi T. Neuroprotection (in Japanese). J Jpn Clin Anesth. 2007;27:588–98.CrossRef
83.
Zurück zum Zitat Prass K, Meisel C, Hoflich C, Braun J, Halle E, Wolf T, et al. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by post-stroke T helper cell type 1 like immunostimulation. J Exp Med. 2003;198:725–36.PubMedCrossRef Prass K, Meisel C, Hoflich C, Braun J, Halle E, Wolf T, et al. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by post-stroke T helper cell type 1 like immunostimulation. J Exp Med. 2003;198:725–36.PubMedCrossRef
84.
Zurück zum Zitat Nessler J, Nessler B, Kitlinski M, Gackowski A, Piwowarska W, Stepniewski M. Concentration of BNP, endothelin 1, pro-inflammatory cytokines (TNF-alpha, IL-6) and exercise capacity in patients with heart failure treated with carvedilol. Kardiol Pol. 2008;66:144–51.PubMed Nessler J, Nessler B, Kitlinski M, Gackowski A, Piwowarska W, Stepniewski M. Concentration of BNP, endothelin 1, pro-inflammatory cytokines (TNF-alpha, IL-6) and exercise capacity in patients with heart failure treated with carvedilol. Kardiol Pol. 2008;66:144–51.PubMed
85.
Zurück zum Zitat Sachs D, Cunha FQ, Poole S, Ferreira SH. Tumor necrosis factor-alpha, interleukin-1 beta and interleukin-8 induce persistent mechanical nociceptor hypersensitivity. Pain. 2002;96:89–97.PubMedCrossRef Sachs D, Cunha FQ, Poole S, Ferreira SH. Tumor necrosis factor-alpha, interleukin-1 beta and interleukin-8 induce persistent mechanical nociceptor hypersensitivity. Pain. 2002;96:89–97.PubMedCrossRef
86.
Zurück zum Zitat Nishio R, Shioi T, Sasayama S, Matsumori A. Carvedilol increases the production of interleukin-12 and interferon-gamma and improves the survival of mice infected with the encephalomyocarditis virus. J Am Coll Cardiol. 2003;41:340–5.PubMedCrossRef Nishio R, Shioi T, Sasayama S, Matsumori A. Carvedilol increases the production of interleukin-12 and interferon-gamma and improves the survival of mice infected with the encephalomyocarditis virus. J Am Coll Cardiol. 2003;41:340–5.PubMedCrossRef
87.
Zurück zum Zitat Klehmet J, Harms H, Richter M, Prass K, Volk HD, Dirnagl U, et al. Stroke-induced immunodepression and post-stroke infections: lessons from the preventive antibacterial therapy in stroke trial. Neuroscience. 2008;13:1–13. Klehmet J, Harms H, Richter M, Prass K, Volk HD, Dirnagl U, et al. Stroke-induced immunodepression and post-stroke infections: lessons from the preventive antibacterial therapy in stroke trial. Neuroscience. 2008;13:1–13.
88.
Zurück zum Zitat Woiciechowsky C, Asadullah K, Nestler D, Eberhardt B, Platzer C, Schoning B, et al. Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury. Nat Med. 1998;4:808–13.PubMedCrossRef Woiciechowsky C, Asadullah K, Nestler D, Eberhardt B, Platzer C, Schoning B, et al. Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury. Nat Med. 1998;4:808–13.PubMedCrossRef
89.
Zurück zum Zitat Katafuchi T, Take S, Hori T. Roles of sympathetic nervous system in the suppression of cytotoxicity of splenic natural killer cells in the rat. J Physiol. 1993;465:343–57.PubMed Katafuchi T, Take S, Hori T. Roles of sympathetic nervous system in the suppression of cytotoxicity of splenic natural killer cells in the rat. J Physiol. 1993;465:343–57.PubMed
90.
Zurück zum Zitat Cheng X, Liao YH, Li B, Yang YL, Zhang JY, Lu BJ, et al. Effects of early treatment with metoprolol on myocardial inflammatory cytokine expression and heart function in rats with acute myocardial infarction. Zhonghua Xin Xue Guan Bing Za Zhi. 2005;33:448–52.PubMed Cheng X, Liao YH, Li B, Yang YL, Zhang JY, Lu BJ, et al. Effects of early treatment with metoprolol on myocardial inflammatory cytokine expression and heart function in rats with acute myocardial infarction. Zhonghua Xin Xue Guan Bing Za Zhi. 2005;33:448–52.PubMed
91.
Zurück zum Zitat Li B, Liao YH, Cheng X, Ge H, Guo H, Wang M. Effects of carvedilol on cardiac cytokines expression and remodeling in rat with acute myocardial infarction. Int J Cardiol. 2006;111:247–55.PubMedCrossRef Li B, Liao YH, Cheng X, Ge H, Guo H, Wang M. Effects of carvedilol on cardiac cytokines expression and remodeling in rat with acute myocardial infarction. Int J Cardiol. 2006;111:247–55.PubMedCrossRef
92.
Zurück zum Zitat Prabhu SD, Chandrasekar B, Murray DR, Freeman GL. Beta-adrenergic blockade in developing heart failure. Effects on myocardial inflammatory cytokines, nitric oxide, and remodeling. Circulation. 2000;101:2103–9.PubMed Prabhu SD, Chandrasekar B, Murray DR, Freeman GL. Beta-adrenergic blockade in developing heart failure. Effects on myocardial inflammatory cytokines, nitric oxide, and remodeling. Circulation. 2000;101:2103–9.PubMed
93.
Zurück zum Zitat Gullestad L, Ueland T, Brunsviq A, Kiekshus J, Simonsen S, Froland SS. Effect of metoprolol on cytokine levels in chronic heart failure––a substudy in the metoprolol controlled-release randomized intervention trial in heart failure (MERIT-HF). Am Heart J. 2001;141:418–21.PubMedCrossRef Gullestad L, Ueland T, Brunsviq A, Kiekshus J, Simonsen S, Froland SS. Effect of metoprolol on cytokine levels in chronic heart failure––a substudy in the metoprolol controlled-release randomized intervention trial in heart failure (MERIT-HF). Am Heart J. 2001;141:418–21.PubMedCrossRef
94.
Zurück zum Zitat Loiek A, Pecivova J, Macickova T, Nosal R, Papezikova I, Ciz M. Effect of carvedilol on the production of reactive oxygen species by HL-60 cells. Neuro Endocrinol Lett. 2008;29:779–83. Loiek A, Pecivova J, Macickova T, Nosal R, Papezikova I, Ciz M. Effect of carvedilol on the production of reactive oxygen species by HL-60 cells. Neuro Endocrinol Lett. 2008;29:779–83.
95.
Zurück zum Zitat Lang CH, Nystrom G, Frost RA. Beta-adrenergic blockade exacerbates sepsis-induced changes in tumor necrosis factor alpha and interleukin-6 in skeletal muscle and is associated with impaired translation initiation. J Trauma. 2008;64:477–86.PubMedCrossRef Lang CH, Nystrom G, Frost RA. Beta-adrenergic blockade exacerbates sepsis-induced changes in tumor necrosis factor alpha and interleukin-6 in skeletal muscle and is associated with impaired translation initiation. J Trauma. 2008;64:477–86.PubMedCrossRef
96.
Zurück zum Zitat Schmitz D, Wilsenack K, Lendemanns S, Schedlowski M, Oberbeck R. Beta-adrenergic blockade during systemic inflammation: impact on cellular immune functions and survival in a murine model of sepsis. Resuscitation. 2007;72:286–94.PubMedCrossRef Schmitz D, Wilsenack K, Lendemanns S, Schedlowski M, Oberbeck R. Beta-adrenergic blockade during systemic inflammation: impact on cellular immune functions and survival in a murine model of sepsis. Resuscitation. 2007;72:286–94.PubMedCrossRef
97.
Zurück zum Zitat Jeschke MG, Norbury WB, Finnerty CC, Branski LK, Herndon DN. Propranolol does not increase inflammation, sepsis, or infectious episodes in severely burned children. J Trauma. 2007;62:676–81.PubMedCrossRef Jeschke MG, Norbury WB, Finnerty CC, Branski LK, Herndon DN. Propranolol does not increase inflammation, sepsis, or infectious episodes in severely burned children. J Trauma. 2007;62:676–81.PubMedCrossRef
98.
Zurück zum Zitat Oberbeck R. Catecholamines: physiological immunomodulators during health and illness. Curr Med Chem. 2006;13:1970–89.CrossRef Oberbeck R. Catecholamines: physiological immunomodulators during health and illness. Curr Med Chem. 2006;13:1970–89.CrossRef
99.
Zurück zum Zitat Benish M, Bartal I, Goldfarb Y, Levi B, Avraham R, Raz A, et al. Perioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis. Ann Surg Oncol. 2008;15:2042–52.PubMedCrossRef Benish M, Bartal I, Goldfarb Y, Levi B, Avraham R, Raz A, et al. Perioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis. Ann Surg Oncol. 2008;15:2042–52.PubMedCrossRef
100.
Zurück zum Zitat McBride WT, Armstrong MA, McBridge SJ. Immunomodulation: an important concept in modern anaesthesia. Anaesthesia. 1996;51:465–73.PubMedCrossRef McBride WT, Armstrong MA, McBridge SJ. Immunomodulation: an important concept in modern anaesthesia. Anaesthesia. 1996;51:465–73.PubMedCrossRef
101.
Zurück zum Zitat Nquyen LP, Omoluabi O, Parra S, Frieske JM, Clement C, Ammar-Aouchiche Z, et al. Chronic exposure to beta-blockers attenuates inflammation and mucin content in a murine asthma model. Am J Respir Cell Mol Biol. 2008;38:256–62.CrossRef Nquyen LP, Omoluabi O, Parra S, Frieske JM, Clement C, Ammar-Aouchiche Z, et al. Chronic exposure to beta-blockers attenuates inflammation and mucin content in a murine asthma model. Am J Respir Cell Mol Biol. 2008;38:256–62.CrossRef
102.
Zurück zum Zitat Brimioulle S, Vachiery JL, Brichant JF, Delcroix M, Lejeune P, Naeije R. Sympathetic modulation of hypoxic pulmonary vasoconstriction in intact dogs. Cardiovasc Res. 1997;34:384–92.PubMedCrossRef Brimioulle S, Vachiery JL, Brichant JF, Delcroix M, Lejeune P, Naeije R. Sympathetic modulation of hypoxic pulmonary vasoconstriction in intact dogs. Cardiovasc Res. 1997;34:384–92.PubMedCrossRef
103.
Zurück zum Zitat Shirai M, Shindo T, Ninomiya I. Beta-adrenergic mechanisms attenuate hypoxic pulmonary vasoconstriction during systemic hypoxia in cats. Am J Physiol. 1994;266:H1777–85.PubMed Shirai M, Shindo T, Ninomiya I. Beta-adrenergic mechanisms attenuate hypoxic pulmonary vasoconstriction during systemic hypoxia in cats. Am J Physiol. 1994;266:H1777–85.PubMed
104.
Zurück zum Zitat Turner DAB, Shribman AJ, Smith G, Achola KJ. Effect of halothane on cardiovascular and plasma catecholamine responses to tracheal intubation. Br J Anaesth. 1986;58:1365–70.PubMedCrossRef Turner DAB, Shribman AJ, Smith G, Achola KJ. Effect of halothane on cardiovascular and plasma catecholamine responses to tracheal intubation. Br J Anaesth. 1986;58:1365–70.PubMedCrossRef
105.
Zurück zum Zitat Stoelting RK. Circulatory changes during direct laryngoscopy and tracheal intubation; influence of duration of laryngoscopy with or without lidocaine. Anesthesiology. 1977;47:381–4.PubMedCrossRef Stoelting RK. Circulatory changes during direct laryngoscopy and tracheal intubation; influence of duration of laryngoscopy with or without lidocaine. Anesthesiology. 1977;47:381–4.PubMedCrossRef
106.
Zurück zum Zitat Angelard B, Debry C, Planquart X, Dubos S, Dominici L, Gondret R. Difficult intubation. A prospective study. Ann Otolaryngol Chir Cervicofac. 1991;108:241–3.PubMed Angelard B, Debry C, Planquart X, Dubos S, Dominici L, Gondret R. Difficult intubation. A prospective study. Ann Otolaryngol Chir Cervicofac. 1991;108:241–3.PubMed
107.
Zurück zum Zitat Bucx MJL, Van Geel RTM, Scheck PAE, Stijnen T. Cardiovascular effects of forces applied during laryngoscopy. The importance of tracheal intubation. Anaesthesia. 1992;47:1029–33.PubMedCrossRef Bucx MJL, Van Geel RTM, Scheck PAE, Stijnen T. Cardiovascular effects of forces applied during laryngoscopy. The importance of tracheal intubation. Anaesthesia. 1992;47:1029–33.PubMedCrossRef
108.
Zurück zum Zitat Vohra A, Kumar S, Charlton AJ, Olukoga AO, Boulton AJ, McLeod D. Effect of diabetes mellitus on the cardiovascular responses to induction of anesthesia and tracheal intubation. Br J Anaesth. 1993;71:258–61.PubMedCrossRef Vohra A, Kumar S, Charlton AJ, Olukoga AO, Boulton AJ, McLeod D. Effect of diabetes mellitus on the cardiovascular responses to induction of anesthesia and tracheal intubation. Br J Anaesth. 1993;71:258–61.PubMedCrossRef
109.
Zurück zum Zitat Low JM, Harvey JT, Prys-Roberts C, Olukoga AO, Boulton AJ, McLeod D. Studies of anesthesia in relation to hypertension. VII. Adrenergic responses to laryngoscopy. Br J Anaesth. 1986;58:471–7.PubMedCrossRef Low JM, Harvey JT, Prys-Roberts C, Olukoga AO, Boulton AJ, McLeod D. Studies of anesthesia in relation to hypertension. VII. Adrenergic responses to laryngoscopy. Br J Anaesth. 1986;58:471–7.PubMedCrossRef
110.
Zurück zum Zitat Roy WL, Edelist G, Gilbert B. Myocardial ischemia during non-cardiac surgery procedures in patients with coronary artery disease. Anesthesiology. 1979;51:393–7.PubMedCrossRef Roy WL, Edelist G, Gilbert B. Myocardial ischemia during non-cardiac surgery procedures in patients with coronary artery disease. Anesthesiology. 1979;51:393–7.PubMedCrossRef
111.
Zurück zum Zitat Fox EJ, Sklar GS, Hill CH, Villanueva R, King BD. Complications related to the pressure responses to endotracheal intubation. Anesthesiology. 1977;47:524–5.PubMedCrossRef Fox EJ, Sklar GS, Hill CH, Villanueva R, King BD. Complications related to the pressure responses to endotracheal intubation. Anesthesiology. 1977;47:524–5.PubMedCrossRef
112.
Zurück zum Zitat Figueredo E, Garcia-Fuentes EM. Assessment of the efficacy of esmolol on the hemodynamic changes induced by laryngoscopy and tracheal intubation. Acta Anaesthesiol Scand. 2001;45:1011–22.PubMedCrossRef Figueredo E, Garcia-Fuentes EM. Assessment of the efficacy of esmolol on the hemodynamic changes induced by laryngoscopy and tracheal intubation. Acta Anaesthesiol Scand. 2001;45:1011–22.PubMedCrossRef
113.
Zurück zum Zitat Mio Y. New ultra-short-acting beta-blockers: landiolol and esmolol(in Japanese). Masui. 2006;55:841–8.PubMed Mio Y. New ultra-short-acting beta-blockers: landiolol and esmolol(in Japanese). Masui. 2006;55:841–8.PubMed
114.
Zurück zum Zitat Onaka M, Yamamoto H. Effects of continuous infusion of landiolol on the hemodynamic response to tracheal intubation (in Japanese). Masui. 2006;55:174–8.PubMed Onaka M, Yamamoto H. Effects of continuous infusion of landiolol on the hemodynamic response to tracheal intubation (in Japanese). Masui. 2006;55:174–8.PubMed
115.
Zurück zum Zitat Kitamura A, Sakamoto A, Inoue T, Ogawa R. Efficacy of an ultrashort-acting beta-adrenergic blocker (ONO-1101) in attenuating cardiovascular responses to endotracheal intubation. Eur J Clin Pharmacol. 1997;51:467–71.PubMedCrossRef Kitamura A, Sakamoto A, Inoue T, Ogawa R. Efficacy of an ultrashort-acting beta-adrenergic blocker (ONO-1101) in attenuating cardiovascular responses to endotracheal intubation. Eur J Clin Pharmacol. 1997;51:467–71.PubMedCrossRef
116.
Zurück zum Zitat Hasuo H, Tomiyasu S, Hojo M, Fujigaki T, Fukusaki M, Sumikawa K. Effect of ONO-1101, a novel short-acting beta-blocker, on hemodynamic responses to isoflurane inhalation and tracheal intubation. J Anesth. 1998;12:115–8.CrossRef Hasuo H, Tomiyasu S, Hojo M, Fujigaki T, Fukusaki M, Sumikawa K. Effect of ONO-1101, a novel short-acting beta-blocker, on hemodynamic responses to isoflurane inhalation and tracheal intubation. J Anesth. 1998;12:115–8.CrossRef
117.
Zurück zum Zitat Yamazaki A, Kinoshita H, Shimogai M, Fujii K, Nakahata K, Hironaka Y, et al. Landiolol attenuates tachycardia in response to endotracheal intubation without affecting blood pressure. Can J Anaesth. 2005;52:254–7.PubMedCrossRef Yamazaki A, Kinoshita H, Shimogai M, Fujii K, Nakahata K, Hironaka Y, et al. Landiolol attenuates tachycardia in response to endotracheal intubation without affecting blood pressure. Can J Anaesth. 2005;52:254–7.PubMedCrossRef
118.
Zurück zum Zitat Oda Y, Nishikawa K, Hase I, Asada A. The short-acting beta-1 adrenoceptor antagonists esmolol and landiolol suppress the bispectral index response to tracheal intubation during sevoflurane anesthesia. Anesth Analg. 2005;100:733–7.PubMedCrossRef Oda Y, Nishikawa K, Hase I, Asada A. The short-acting beta-1 adrenoceptor antagonists esmolol and landiolol suppress the bispectral index response to tracheal intubation during sevoflurane anesthesia. Anesth Analg. 2005;100:733–7.PubMedCrossRef
119.
Zurück zum Zitat Sugiura S, Seki S, Hidaka K, Masuoka M, Tsuchida H. The hemodynamic effects of landiolol, an ultra-short acting beta-1 selective blocker, on endotracheal intubation in patients with and without hypertension. Anesth Analg. 2007;104:124–9.PubMedCrossRef Sugiura S, Seki S, Hidaka K, Masuoka M, Tsuchida H. The hemodynamic effects of landiolol, an ultra-short acting beta-1 selective blocker, on endotracheal intubation in patients with and without hypertension. Anesth Analg. 2007;104:124–9.PubMedCrossRef
120.
Zurück zum Zitat Dyson A, Isaac PA, Pennant JH, Giesecke AH, Lipton JM. Esmolol attenuates cardiovascular responses to extubation. Anesth Analg. 1990;71:675–8.PubMedCrossRef Dyson A, Isaac PA, Pennant JH, Giesecke AH, Lipton JM. Esmolol attenuates cardiovascular responses to extubation. Anesth Analg. 1990;71:675–8.PubMedCrossRef
121.
Zurück zum Zitat Kurian SM, Evans R, Fernandes NO, Sherry KM. The effect of an infusion of esmolol on the incidence of myocardial ischemia during tracheal extubation following coronary artery surgery. Anaesthesia. 2001;56:1163–8.PubMedCrossRef Kurian SM, Evans R, Fernandes NO, Sherry KM. The effect of an infusion of esmolol on the incidence of myocardial ischemia during tracheal extubation following coronary artery surgery. Anaesthesia. 2001;56:1163–8.PubMedCrossRef
122.
Zurück zum Zitat Kovac AL, Massiongale A. Comparison of nicardipine versus esmolol in attenuating the hemodynamic responses to anesthesia emergence and extubation. J Cardiothorac Vasc Anesth. 2007;21:45–50.PubMedCrossRef Kovac AL, Massiongale A. Comparison of nicardipine versus esmolol in attenuating the hemodynamic responses to anesthesia emergence and extubation. J Cardiothorac Vasc Anesth. 2007;21:45–50.PubMedCrossRef
123.
Zurück zum Zitat Grillo P, Bruder N, Auquier P, Pellissier D, Gouin F. Esmolol blunts the cerebral blood flow velocity increase during emergence from anesthesia in neurosurgical patients. Anesth Analg. 2003;96:1145–9.PubMedCrossRef Grillo P, Bruder N, Auquier P, Pellissier D, Gouin F. Esmolol blunts the cerebral blood flow velocity increase during emergence from anesthesia in neurosurgical patients. Anesth Analg. 2003;96:1145–9.PubMedCrossRef
124.
Zurück zum Zitat Nonaka A, Suzuki S, Abe F. The effects of continuous infusion of landiolol on heart rate changes after neostigmine-atropine administration during recovery from general anesthesia (in Japanese). Masui. 2006;55:1459–62.PubMed Nonaka A, Suzuki S, Abe F. The effects of continuous infusion of landiolol on heart rate changes after neostigmine-atropine administration during recovery from general anesthesia (in Japanese). Masui. 2006;55:1459–62.PubMed
125.
Zurück zum Zitat Nakagawa H, Nanba M, Okayama Y. Landiolol prevented myocardial ischemia in a patient with severe aortic stenosis undergoing total gastrectomy (in Japanese). Masui. 2007;56:582–5.PubMed Nakagawa H, Nanba M, Okayama Y. Landiolol prevented myocardial ischemia in a patient with severe aortic stenosis undergoing total gastrectomy (in Japanese). Masui. 2007;56:582–5.PubMed
126.
Zurück zum Zitat Shirasaka T, Iwasaki T, Hosokawa N, Komatsu M, Kasaba T, Takasaki M. Effects of landiolol on the cardiovascular response during tracheal extubation. J Anesth. 2008;22:322–5.PubMedCrossRef Shirasaka T, Iwasaki T, Hosokawa N, Komatsu M, Kasaba T, Takasaki M. Effects of landiolol on the cardiovascular response during tracheal extubation. J Anesth. 2008;22:322–5.PubMedCrossRef
127.
Zurück zum Zitat Gress TW, Nieto FJ, Shahar E, Wofford MR, Brancati FL. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis risk in communities study. N Engl J Med. 2000;342:905–12.PubMedCrossRef Gress TW, Nieto FJ, Shahar E, Wofford MR, Brancati FL. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis risk in communities study. N Engl J Med. 2000;342:905–12.PubMedCrossRef
128.
Zurück zum Zitat Bakris GL, Fonseca V, Katholi RE, McGill JB, Messerli FH, Phillips RA, et al. Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension. JAMA. 2004;292:2227–36.PubMedCrossRef Bakris GL, Fonseca V, Katholi RE, McGill JB, Messerli FH, Phillips RA, et al. Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension. JAMA. 2004;292:2227–36.PubMedCrossRef
129.
Zurück zum Zitat Day JL, Metcalfe J, Simpson CN. Adrenergic mechanisms in control of plasma lipid concentration. Br Med J. 1982;284:1145–8.CrossRef Day JL, Metcalfe J, Simpson CN. Adrenergic mechanisms in control of plasma lipid concentration. Br Med J. 1982;284:1145–8.CrossRef
130.
Zurück zum Zitat Kjeldsen SE, Syvertsen JO, Hedner T. Cardiac conduction with diltiazem and beta-blockade combined. A review and report on cases. Blood Press. 1996;5:260–3.PubMedCrossRef Kjeldsen SE, Syvertsen JO, Hedner T. Cardiac conduction with diltiazem and beta-blockade combined. A review and report on cases. Blood Press. 1996;5:260–3.PubMedCrossRef
131.
Zurück zum Zitat Brouwer RM, Follath F, Buhler FR. Review of the cardiovascular adversity of the calcium antagonist beta-blocker combination: implications for antihypertensive therapy. J Cardiovasc Pharmacol. 1985;7:S38–44.PubMedCrossRef Brouwer RM, Follath F, Buhler FR. Review of the cardiovascular adversity of the calcium antagonist beta-blocker combination: implications for antihypertensive therapy. J Cardiovasc Pharmacol. 1985;7:S38–44.PubMedCrossRef
132.
Zurück zum Zitat Westphal K, Weinbrenner A, Giessmann T, Stuhr M, Franke G, Zschiesche M, et al. Oral bioavailability of digoxin is enhanced by talinolol: evidence for involvement of intestinal P-glycoprotein. Clin Pharmacol Ther. 2000;68(1):6–12.PubMedCrossRef Westphal K, Weinbrenner A, Giessmann T, Stuhr M, Franke G, Zschiesche M, et al. Oral bioavailability of digoxin is enhanced by talinolol: evidence for involvement of intestinal P-glycoprotein. Clin Pharmacol Ther. 2000;68(1):6–12.PubMedCrossRef
133.
Zurück zum Zitat Lilja M, Jounela AJ, Juustila H, Mattila MJ. Interaction of clonidine and beta-blockers. Acta Med Scand. 1980;207:173–6.PubMed Lilja M, Jounela AJ, Juustila H, Mattila MJ. Interaction of clonidine and beta-blockers. Acta Med Scand. 1980;207:173–6.PubMed
134.
Zurück zum Zitat Garvey HL, Woodhouse BL. Reversal of clonidine-induced hypotension by beta-adrenoceptor blocking drugs. Eur J Pharmacol. 1980;65:55–62.PubMedCrossRef Garvey HL, Woodhouse BL. Reversal of clonidine-induced hypotension by beta-adrenoceptor blocking drugs. Eur J Pharmacol. 1980;65:55–62.PubMedCrossRef
135.
Zurück zum Zitat Haidar SH, Moreton JE, Liang Z, Hoke JF, Muir KT, Eddington ND. The pharmacokinetics and electroencephalogram response of remifentanil alone and in combination with esmolol in the rat. Pharm Res. 1997;14:1817–23.PubMedCrossRef Haidar SH, Moreton JE, Liang Z, Hoke JF, Muir KT, Eddington ND. The pharmacokinetics and electroencephalogram response of remifentanil alone and in combination with esmolol in the rat. Pharm Res. 1997;14:1817–23.PubMedCrossRef
136.
Zurück zum Zitat Haidar SH, Moreton JE, Liang Z, Hoke JF, Muir KT, Eddington ND. Evaluating a possible pharmacokinetic interaction between remifentanil and esmolol in the rat. J Pharm Sci. 1997;86:1278–82.PubMedCrossRef Haidar SH, Moreton JE, Liang Z, Hoke JF, Muir KT, Eddington ND. Evaluating a possible pharmacokinetic interaction between remifentanil and esmolol in the rat. J Pharm Sci. 1997;86:1278–82.PubMedCrossRef
137.
Zurück zum Zitat Zhou W, Fontenot HJ, Wang SN, Kennedy RH. Propofol-induced alterations in myocardial beta-adrenoceptor binding and responsiveness. Anesth Analg. 1999;89:604–8.PubMedCrossRef Zhou W, Fontenot HJ, Wang SN, Kennedy RH. Propofol-induced alterations in myocardial beta-adrenoceptor binding and responsiveness. Anesth Analg. 1999;89:604–8.PubMedCrossRef
138.
Zurück zum Zitat Hanouz JL, Riou B, Massias L, Lecarpentier Y, Coriat P. Interaction of halothane with alpha- and beta-adrenoceptor stimulations in rat myocardium. Anesthesiology. 1997;86:147–59.PubMedCrossRef Hanouz JL, Riou B, Massias L, Lecarpentier Y, Coriat P. Interaction of halothane with alpha- and beta-adrenoceptor stimulations in rat myocardium. Anesthesiology. 1997;86:147–59.PubMedCrossRef
139.
Zurück zum Zitat Gueugniaud PY, Hanouz JL, Martino JM, Lecarpentier Y, Coriat P, Riou B. Interaction of halogenated anesthetics with dobutamine in rat myocardium. Anesthesiology. 1999;90:1663–70.PubMedCrossRef Gueugniaud PY, Hanouz JL, Martino JM, Lecarpentier Y, Coriat P, Riou B. Interaction of halogenated anesthetics with dobutamine in rat myocardium. Anesthesiology. 1999;90:1663–70.PubMedCrossRef
140.
Zurück zum Zitat Hanouz JL, Vivien B, Gueugniaud PY, Lecarpentier Y, Coriat P, Riou B. Interaction of isoflurane and sevoflurane with alpha- and beta-adrenoceptor stimulations in rat myocardium. Anesthesiology. 1998;88:1249–58.PubMedCrossRef Hanouz JL, Vivien B, Gueugniaud PY, Lecarpentier Y, Coriat P, Riou B. Interaction of isoflurane and sevoflurane with alpha- and beta-adrenoceptor stimulations in rat myocardium. Anesthesiology. 1998;88:1249–58.PubMedCrossRef
Metadaten
Titel
Possible indications of beta-blockers in the perioperative period other than prevention of cardiac ischemia
verfasst von
Yuji Kadoi
Shigeru Saito
Publikationsdatum
01.02.2010
Verlag
Springer Japan
Erschienen in
Journal of Anesthesia / Ausgabe 1/2010
Print ISSN: 0913-8668
Elektronische ISSN: 1438-8359
DOI
https://doi.org/10.1007/s00540-009-0865-x

Weitere Artikel der Ausgabe 1/2010

Journal of Anesthesia 1/2010 Zur Ausgabe

Mit dem Seitenschneider gegen das Reißverschluss-Malheur

03.06.2024 Urologische Notfallmedizin Nachrichten

Wer ihn je erlebt hat, wird ihn nicht vergessen: den Schmerz, den die beim Öffnen oder Schließen des Reißverschlusses am Hosenschlitz eingeklemmte Haut am Penis oder Skrotum verursacht. Eine neue Methode für rasche Abhilfe hat ein US-Team getestet.

Schlaganfall: frühzeitige Blutdrucksenkung im Krankenwagen ohne Nutzen

31.05.2024 Apoplex Nachrichten

Der optimale Ansatz für die Blutdruckkontrolle bei Patientinnen und Patienten mit akutem Schlaganfall ist noch nicht gefunden. Ob sich eine frühzeitige Therapie der Hypertonie noch während des Transports in die Klinik lohnt, hat jetzt eine Studie aus China untersucht.

Reanimation bei Kindern – besser vor Ort oder während Transport?

29.05.2024 Reanimation im Kindesalter Nachrichten

Zwar scheint es laut einer Studie aus den USA und Kanada bei der Reanimation von Kindern außerhalb einer Klinik keinen Unterschied für das Überleben zu machen, ob die Wiederbelebungsmaßnahmen während des Transports in die Klinik stattfinden oder vor Ort ausgeführt werden. Jedoch gibt es dabei einige Einschränkungen und eine wichtige Ausnahme.

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.